ResearcherShanghai Jiao Tong UniversityNo recent work listed

Jingpiao Bao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1285-142X; OpenAlex author ID A5050572661. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1282120 ↗
Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2022.834728 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bin Li · 2 shared papers, 2022–2023 · strength 0.36
- Paper Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2023.1282120 ↗
- Paper Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2022.834728 ↗
Guoyong Hu · 2 shared papers, 2022–2023 · strength 0.36
- Paper Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2023.1282120 ↗
- Paper Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2022.834728 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.